In a research note published on Tuesday, stock analysts at Piper Sandler lowered their price objective for Neogen (NASDAQ: NEOG) from $26.00 to $20.00. This information got obtained from a report that The Fly published. According to the findings of Piper Sandler’s investigation into the market, it is highly likely that prices will go down by 7.15 percent compared to the company’s most recent closing price. On Tuesday, shares of NASDAQ: NEOG started trading for $21.54 per share.
During the last twelve months, the price of Neogen ranged from a low of $20.20 to a high of $47.80. The company’s price-to-earnings ratio is 47.87, and its beta value is equal to 0.58. It is currently valued at $2.32 billion on the market. The stock now has a simple moving average of $22.48 over the past 50 days and a simple moving average of $27.35 over the past 200 days. Director Ronald D. Green invested in Neogen on August 2 by purchasing 1,500 shares of the company’s stock. This transaction took place on a business day. In addition to the other recent happenings regarding Neogen, this was one of them. The number of shares was acquired for a total cost of $33,750.00, which comes out to an average price of approximately $22.50 per share.
After the transaction got finalized, the director was left with a total of 10,694 shares of the company, which are currently valued at a sum of $240,615. An SEC filing that explains the transaction in greater detail has been made public and may be viewed on the website of the Securities and Exchange Commission (SEC). In related news, Director James P. Tobin made a recent purchase of 2,000 shares of Neogen stock on July 27. This piece of information is relevant to this topic. The stock was acquired at an average price of $22.98 per share, which resulted in a total expenditure of $45,960.00 to purchase the stock.
The stock price was calculated as follows: After the sale was finalized, the director was vested with direct ownership of 14,000 business shares, each of which had an estimated value of $321,720. The Securities and Exchange Commission (SEC) keeps a legal file open to the public and can be read online. This file had information relevant to the transaction, which was discovered there. Neogen director Ronald D. Green also purchased 1,500 shares of the company’s stock on Tuesday, August 2. The shares were purchased at an average price of $22.50 per share, bringing the total amount spent on purchasing the shares to $33,750.00. The market determined the price of the shares. Following the completion of the transaction, the director now has a total of 10,694 shares of the company’s stock, which has a value of $240,615.
You should look in this spot if you are looking for the disclosure that pertains to this transaction. Business insiders spent a combined total of $507,448 during the most recent fiscal period to purchase 22,100 shares of the company’s stock. There is currently insider stock ownership in the amount of 0.52% of the corporation. Recent months have seen several prominent investors adjust how they hold their NEOG shares. GW&K Investment Management LLC acquired a new stake in Neogen for twenty-seven thousand dollars during the first three months of 2018. An amazing 87.5% more Neogen was added to Patriot Financial Group Insurance Agency LLC’s holdings during the first three months of 2018. After purchasing an additional 426 shares during the most recent quarter of the fiscal year, The Patriot Financial Group Insurance Agency LLC now has a total of 913 shares of the company’s stock, which are currently valued at a sum of $28,000. These shares were acquired.
During the fourth quarter of 2011, First Horizon Advisors Inc. increased its holdings of Neogen stock by 372.5 percent. After making an additional acquisition of 529 shares during the most recent quarter, First Horizon Advisors Inc. now has a total of 671 shares in the company. These shares are valued at $30,000 and comprise the company’s ownership. Neogen received a financial contribution of $34,000 from Exchange Traded Concepts LLC during the first three months of 2018. Pinebridge Investments L.P. made a brand new investment in the form of $41,000 worth of Neogen shares over the year’s final three months. It is by no means the least important item on this list. Various institutions own most of the company’s shares (97.86%). Neogen Corporation, along with its many fully owned subsidiaries, creates, manufactures, and sells a wide variety of goods worldwide to assure the health and safety of animals and food.
These products are designed, manufactured, and distributed to ensure these outcomes. It is divided into two parts, the first of which is devoted to protecting animals and the second to protecting food. The Food Safety business supplies diagnostic test kits and other associated products to discover potentially dangerous and unexpected compounds in food and animal feed. These ingredients are found in both human and animal consumption. Foodborne diseases, organisms that cause spoilage, natural toxins, food allergens, genetic changes, ruminant byproducts, meat speciation, drug residues, pesticide residues, and general sanitation concerns are all examples of these potentially dangerous and unintentional elements. In addition, it comes with a speedy sanitation test known as AccuPoint Advanced that examines the sample for the chemical that messed with the adenosine triphosphate.
